
Sign up to save your podcasts
Or


Dr Bill Nelson and Dr Nilo Azad discuss the decades-long research effort to develop treatments targeting KRAS mutations and the importance of federal funding in bringing those treatments to patients.
By Johns Hopkins Kimmel Cancer Center4.6
99 ratings
Dr Bill Nelson and Dr Nilo Azad discuss the decades-long research effort to develop treatments targeting KRAS mutations and the importance of federal funding in bringing those treatments to patients.

32,214 Listeners

40 Listeners

5 Listeners

26 Listeners

829 Listeners

5 Listeners

304 Listeners

112,858 Listeners

56,917 Listeners

334 Listeners

45 Listeners

16 Listeners

2 Listeners

25 Listeners

8,191 Listeners

628 Listeners

58,812 Listeners

155 Listeners

834 Listeners